AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 61 filers reported holding AVROBIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,283,000 | -78.8% | 179,900 | -76.7% | 0.00% | -100.0% |
| Q4 2020 | $10,783,000 | -4.0% | 773,488 | -10.3% | 0.00% | 0.0% |
| Q3 2020 | $11,231,000 | -29.9% | 862,613 | -6.0% | 0.00% | -50.0% |
| Q2 2020 | $16,014,000 | +16.0% | 917,667 | +3.5% | 0.00% | 0.0% |
| Q1 2020 | $13,800,000 | +298.2% | 886,871 | +415.1% | 0.00% | +300.0% |
| Q4 2019 | $3,466,000 | +43.1% | 172,191 | +0.4% | 0.00% | 0.0% |
| Q3 2019 | $2,422,000 | -44.4% | 171,555 | -35.9% | 0.00% | 0.0% |
| Q2 2019 | $4,354,000 | -72.5% | 267,735 | -62.7% | 0.00% | -75.0% |
| Q1 2019 | $15,815,000 | +100.4% | 717,242 | +51.3% | 0.00% | +100.0% |
| Q4 2018 | $7,892,000 | +20.9% | 473,999 | +276.5% | 0.00% | +100.0% |
| Q3 2018 | $6,530,000 | +119.6% | 125,880 | +20.9% | 0.00% | 0.0% |
| Q2 2018 | $2,974,000 | – | 104,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |